22-41170430-A-C

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001429.4(EP300):ā€‹c.4311A>Cā€‹(p.Ala1437Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00173 in 1,613,844 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0018 ( 2 hom., cov: 32)
Exomes š‘“: 0.0017 ( 15 hom. )

Consequence

EP300
NM_001429.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.956
Variant links:
Genes affected
EP300 (HGNC:3373): (E1A binding protein p300) This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 22-41170430-A-C is Benign according to our data. Variant chr22-41170430-A-C is described in ClinVar as [Benign]. Clinvar id is 341805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.956 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.00173 (2522/1461606) while in subpopulation EAS AF= 0.0221 (876/39684). AF 95% confidence interval is 0.0209. There are 15 homozygotes in gnomad4_exome. There are 1381 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 275 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
EP300NM_001429.4 linkc.4311A>C p.Ala1437Ala synonymous_variant 27/31 ENST00000263253.9 NP_001420.2 Q09472Q7Z6C1
EP300NM_001362843.2 linkc.4233A>C p.Ala1411Ala synonymous_variant 26/30 NP_001349772.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
EP300ENST00000263253.9 linkc.4311A>C p.Ala1437Ala synonymous_variant 27/311 NM_001429.4 ENSP00000263253.7 Q09472

Frequencies

GnomAD3 genomes
AF:
0.00179
AC:
273
AN:
152118
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00603
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0162
Gnomad SAS
AF:
0.00375
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000838
Gnomad OTH
AF:
0.00383
GnomAD3 exomes
AF:
0.00264
AC:
665
AN:
251470
Hom.:
4
AF XY:
0.00269
AC XY:
365
AN XY:
135908
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.00312
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0133
Gnomad SAS exome
AF:
0.00441
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00133
Gnomad OTH exome
AF:
0.00375
GnomAD4 exome
AF:
0.00173
AC:
2522
AN:
1461606
Hom.:
15
Cov.:
32
AF XY:
0.00190
AC XY:
1381
AN XY:
727102
show subpopulations
Gnomad4 AFR exome
AF:
0.000448
Gnomad4 AMR exome
AF:
0.00338
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.0221
Gnomad4 SAS exome
AF:
0.00432
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000847
Gnomad4 OTH exome
AF:
0.00210
GnomAD4 genome
AF:
0.00181
AC:
275
AN:
152238
Hom.:
2
Cov.:
32
AF XY:
0.00214
AC XY:
159
AN XY:
74436
show subpopulations
Gnomad4 AFR
AF:
0.000337
Gnomad4 AMR
AF:
0.00621
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.0161
Gnomad4 SAS
AF:
0.00375
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000838
Gnomad4 OTH
AF:
0.00379
Alfa
AF:
0.000941
Hom.:
0
Bravo
AF:
0.00233
Asia WGS
AF:
0.00693
AC:
24
AN:
3478
EpiCase
AF:
0.00142
EpiControl
AF:
0.00207

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024EP300: BP4, BP7, BS1, BS2 -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxMay 13, 2019- -
EP300-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMay 02, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2025- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
1.7
DANN
Benign
0.75
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150941761; hg19: chr22-41566434; COSMIC: COSV54327284; COSMIC: COSV54327284; API